Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.45−0.13 (-22.18%)
Close on Nov 13, 2026Market cap $930.08KP/E –Yield –
Curis total assets
Total assets on the balance sheet at the end of each period.
Curis's total assets was $18.80M at Sep 30, 2026. For fiscal 2025 it was $19.97M, down 51.6% from the year before. Over ten years it grew -14.4% a year on average. The highest annual figure on record is $204.36M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.97M | -51.6% |
| FY2024 | Dec 31, 2024 | $41.27M | -46.6% |
| FY2023 | Dec 31, 2023 | $77.28M | -29.0% |
| FY2022 | Dec 31, 2022 | $108.85M | -32.9% |
| FY2021 | Dec 31, 2021 | $162.30M | -20.6% |
| FY2020 | Dec 31, 2020 | $204.36M | +482.1% |
| FY2019 | Dec 31, 2019 | $35.11M | -6.0% |
| FY2018 | Dec 31, 2018 | $37.37M | -49.4% |
| FY2017 | Dec 31, 2017 | $73.80M | +27.8% |
| FY2016 | Dec 31, 2016 | $57.75M | -39.2% |
| FY2015 | Dec 31, 2015 | $94.97M | +51.7% |
| FY2014 | Dec 31, 2014 | $62.61M | -22.3% |
| FY2013 | Dec 31, 2013 | $80.59M | +15.5% |
| FY2012 | Dec 31, 2012 | $69.77M | +44.8% |
| FY2011 | Dec 31, 2011 | $48.18M | -4.9% |
| FY2010 | Dec 31, 2010 | $50.65M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.80M | -32.0% |
| Q2 FY2026 | Jun 30, 2026 | $18.97M | -35.1% |
| Q1 FY2026 | Mar 31, 2026 | $29.69M | -24.5% |
| Q4 FY2025 | Dec 31, 2025 | $19.97M | -51.6% |
| Q3 FY2025 | Sep 30, 2025 | $27.64M | -34.9% |
| Q2 FY2025 | Jun 30, 2025 | $29.23M | -42.0% |
| Q1 FY2025 | Mar 31, 2025 | $39.33M | -36.6% |
| Q4 FY2024 | Dec 31, 2024 | $41.27M | -46.6% |
| Q3 FY2024 | Sep 30, 2024 | $42.47M | -52.8% |
| Q2 FY2024 | Jun 30, 2024 | $50.41M | -40.2% |
| Q1 FY2024 | Mar 31, 2024 | $62.02M | -34.4% |
| Q4 FY2023 | Dec 31, 2023 | $77.28M | -29.0% |
| Q3 FY2023 | Sep 30, 2023 | $89.98M | -26.8% |
| Q2 FY2023 | Jun 30, 2023 | $84.31M | -34.6% |
| Q1 FY2023 | Mar 31, 2023 | $94.54M | -32.8% |
| Q4 FY2022 | Dec 31, 2022 | $108.85M | -32.9% |
| Q3 FY2022 | Sep 30, 2022 | $122.85M | -28.6% |
| Q2 FY2022 | Jun 30, 2022 | $128.83M | -28.9% |
| Q1 FY2022 | Mar 31, 2022 | $140.74M | -26.2% |
| Q4 FY2021 | Dec 31, 2021 | $162.30M | -20.6% |
| Q3 FY2021 | Sep 30, 2021 | $172.09M | +276.4% |
| Q2 FY2021 | Jun 30, 2021 | $181.19M | +303.1% |
| Q1 FY2021 | Mar 31, 2021 | $190.59M | +613.7% |
| Q4 FY2020 | Dec 31, 2020 | $204.36M | +482.1% |
| Q3 FY2020 | Sep 30, 2020 | $45.71M | +8.2% |
| Q2 FY2020 | Jun 30, 2020 | $44.95M | -6.8% |
| Q1 FY2020 | Mar 31, 2020 | $26.71M | -51.8% |
| Q4 FY2019 | Dec 31, 2019 | $35.11M | -6.0% |
| Q3 FY2019 | Sep 30, 2019 | $42.24M | -4.6% |
| Q2 FY2019 | Jun 30, 2019 | $48.24M | -9.3% |
| Q1 FY2019 | Mar 31, 2019 | $55.45M | -9.7% |
| Q4 FY2018 | Dec 31, 2018 | $37.37M | -49.4% |
| Q3 FY2018 | Sep 30, 2018 | $44.27M | -46.3% |
| Q2 FY2018 | Jun 30, 2018 | $53.19M | -16.6% |
| Q1 FY2018 | Mar 31, 2018 | $61.38M | -16.8% |
| Q4 FY2017 | Dec 31, 2017 | $73.80M | +27.8% |
| Q3 FY2017 | Sep 30, 2017 | $82.37M | – |
| Q2 FY2017 | Jun 30, 2017 | $63.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $73.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $57.75M | – |
See a number that looks wrong?